Sumitomo Chemical Company, Limited
Notice Regarding the Recognition of Special Loss (Equity Method Investment Loss) in Individual Financial Statements
In the individual financial statements for the third quarter of the fiscal year ending March 2026, an equity method investment loss of 13,361 million yen was recorded. There is no impact on consolidated earnings.
Key Figures
- Equity Method Investment Loss: 13,361 million yen (Individual Financial Statements for Q3 Fiscal Year Ending March 2026)
- Impact on Consolidated Earnings: None (due to elimination adjustments)
- Accounting Period: October 1, 2025 to December 31, 2025 (Q3)
AI要約
Regarding the Recognition of Special Loss in Individual Financial Statements
In the third quarter of the fiscal year ending March 2026 (October 1, 2025 to December 31, 2025), Sumitomo Chemical Company, Limited recorded an equity method investment loss of 13,361 million yen in its individual financial statements due to a significant decline in the fair value of Class A common shares of Rabigh Refining and Petrochemical Company, an equity method affiliate. The valuation loss is a result of an impairment process, and the quarterly securities valuation adopts a marking-to-market approach.
Consolidated Earnings and Future Outlook
The equity method investment loss recognized this time is recorded only in individual financial statements and is eliminated in the consolidated financial statements; therefore, there is no impact on consolidated earnings. However, the amount of valuation loss recognized may fluctuate depending on the stock market price situation in the fourth quarter.
